Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment
- PMID: 16877571
- PMCID: PMC2564705
- DOI: 10.1136/sti.2005.017368
Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment
Abstract
The evidence that Mycoplasma genitalium is a sexually transmitted pathogen is virtually incontrovertible based on both the concordance rates among partners and on DNA typing showing the same sequence type among partners in contrast to unrelated M genitalium positive patients. The implications that this has for the screening, testing, and treatment of patients is less certain however. Which tests are the most sensitive and specific, what samples are most appropriate, who should be tested, what treatment is best and how should partners be managed?
Conflict of interest statement
Declaration of interests: JR has received consultancy fees from Bayer and Pfizer and is an associate editor of
References
-
- Taylor‐Robinson D. Mycoplasma genitalium—an up‐date. Int J STD AIDS 200213145–151. - PubMed
-
- Zhang S, Wear D J, Lo S‐C. Mycoplasmal infections alter gene expression in cultured human prostatic and cervical epithelial cells. FEMS Immunol Med Microbiol 20002743–50. - PubMed
-
- Svenstrup H F, Fedder J, Abraham‐Peskir J.et al Mycoplasma genitalium attaches to human spermatozoa. Hum Reprod 2003182103–2109. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources